Benchmark Reiterates “Speculative Buy” Rating for Milestone Scientific (NYSE:MLSS)

Milestone Scientific (NYSE:MLSS)‘s stock had its “speculative buy” rating restated by equities research analysts at Benchmark in a report released on Wednesday,Benzinga reports. They presently have a $1.25 price objective on the stock. Benchmark’s price target points to a potential upside of 76.55% from the company’s current price.

Separately, StockNews.com assumed coverage on Milestone Scientific in a research report on Monday. They set a “hold” rating for the company.

Milestone Scientific Price Performance

NYSE:MLSS opened at $0.71 on Wednesday. The firm has a market capitalization of $55.15 million, a P/E ratio of -10.11 and a beta of 1.08. Milestone Scientific has a one year low of $0.52 and a one year high of $1.10. The company’s 50-day simple moving average is $0.83 and its 200 day simple moving average is $0.84.

Insider Activity at Milestone Scientific

In related news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the sale, the director now owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In the last ninety days, insiders have sold 109,193 shares of company stock valued at $101,634. 24.75% of the stock is owned by insiders.

Institutional Trading of Milestone Scientific

A hedge fund recently bought a new stake in Milestone Scientific stock. Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific Inc. (NYSE:MLSS) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 52,368 shares of the company’s stock, valued at approximately $48,000. Y Intercept Hong Kong Ltd owned about 0.07% of Milestone Scientific at the end of the most recent quarter. 5.79% of the stock is currently owned by institutional investors and hedge funds.

About Milestone Scientific

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.